Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 29
Calif. Judge Dismisses Bextra, Celebrex Claims for Failure to Prosecute
Pfizer: Neglecting Discovery Obligations Warrants Plaintiffs' Dismissal
Merck Says American Pipe Can't Save Plaintiffs' Time-Barred Vioxx Claims
N.J. Judge: British Vioxx Plaintiffs Must Seek Damages in U.K. Courts
Pro Athlete Maintains Defendants Properly Joined in Vioxx Suit
Calif. Judge Consolidates Two Cases for State's Second Vioxx Trial
Council Adopts Model Legislation to Strengthen Consumer Protection Laws
Journal Watch, Arthritis Drugs, October 2006
